BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35949404)

  • 1. The Relationship Between Antibiotic Agent and Mortality in Patients With Febrile Neutropenia due to Staphylococcal Bloodstream Infection: A Multicenter Cohort Study.
    Aleissa MM; Gonzalez-Bocco IH; Zekery-Saad S; Kubiak DW; Zhang EM; Signorelli J; Hammond SP; Mohareb AM; Luskin MR; Manne-Goehler J; Marty FM
    Open Forum Infect Dis; 2022 Aug; 9(8):ofac306. PubMed ID: 35949404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of Cefazolin Versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study.
    McDanel JS; Roghmann MC; Perencevich EN; Ohl ME; Goto M; Livorsi DJ; Jones M; Albertson JP; Nair R; O'Shea AMJ; Schweizer ML
    Clin Infect Dis; 2017 Jul; 65(1):100-106. PubMed ID: 28379314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effectiveness of Exclusive Exposure to Nafcillin or Oxacillin, Cefazolin, Piperacillin/Tazobactam, and Fluoroquinolones Among a National Cohort of Veterans With Methicillin-Susceptible
    Beganovic M; Cusumano JA; Lopes V; LaPlante KL; Caffrey AR
    Open Forum Infect Dis; 2019 Jul; 6(7):ofz270. PubMed ID: 31281864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and impact of methicillin-sensitive
    Svishchuk J; Ebbert K; Waddell B; Izydorczyk C; Acosta N; Somayaji R; Rabin HR; Bjornson CL; Lisboa L; Gregson DB; Conly JM; Surette MG; Parkins MD
    Antimicrob Agents Chemother; 2023 Dec; 67(12):e0013623. PubMed ID: 37966229
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of Clinical Outcomes for Glycopeptides and Beta-Lactams in Methicillin-Susceptible
    La YJ; Kim HR; Oh DH; Ahn JY; Kim YC
    Yonsei Med J; 2022 Jul; 63(7):611-618. PubMed ID: 35748072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Reported β-Lactam Allergy on Management of Methicillin-Sensitive
    Veve MP; January SE; Kenney RM; Zoratti EM; Zervos MJ; Davis SL
    J Pharm Pract; 2020 Dec; 33(6):809-814. PubMed ID: 30991876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Ceftriaxone Compared With Cefazolin or Nafcillin/Oxacillin for Outpatient Therapy for Methicillin-Sensitive
    Hamad Y; Nickel KB; Olsen MA; George IA
    Open Forum Infect Dis; 2024 Feb; 11(2):ofad662. PubMed ID: 38352150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of a β-Lactam Prior to Vancomycin as the First Dose of Antibiotic Therapy Improves Survival in Patients With Bloodstream Infections.
    Amoah J; Klein EY; Chiotos K; Cosgrove SE; Tamma PD
    Clin Infect Dis; 2022 Aug; 75(1):98-104. PubMed ID: 34606585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals.
    McDanel JS; Perencevich EN; Diekema DJ; Herwaldt LA; Smith TC; Chrischilles EA; Dawson JD; Jiang L; Goto M; Schweizer ML
    Clin Infect Dis; 2015 Aug; 61(3):361-7. PubMed ID: 25900170
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Mossman AK; Svishchuk J; Waddell BJM; Izydorczyk CS; Buckley PT; Hilliard JJ; Al-Ghalith G; Zheng L; Lynch AS; Mody CH; Lisboa LF; Gregson DB; Parkins MD
    Ann Am Thorac Soc; 2022 Aug; 19(8):1285-1293. PubMed ID: 35213810
    [No Abstract]   [Full Text] [Related]  

  • 11. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
    Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
    Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections.
    Rao SN; Rhodes NJ; Lee BJ; Scheetz MH; Hanson AP; Segreti J; Crank CW; Wang SK
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5232-8. PubMed ID: 26077253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the Beta-Lactam Matter? Nafcillin versus Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections.
    Burrelli CC; Broadbent EK; Margulis A; Snyder GM; Gold HS; McCoy C; Mahoney MV; Hirsch EB
    Chemotherapy; 2018; 63(6):345-351. PubMed ID: 30965335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to empirical β-lactams recommended in febrile neutropenia guidelines in Gram-negative bacilli bloodstream infections in Spain: a multicentre study.
    Chumbita M; Puerta-Alcalde P; Yáñez L; Cuesta MA; Chinea A; Español Morales I; Fernández Abellán P; Gudiol C; Guerreiro M; González-Sierra P; Rojas R; Sánchez Pina JM; Sánchez Vadillo I; Varela R; Vázquez L; Lopera C; Monzó P; Garcia-Vidal C
    J Antimicrob Chemother; 2022 Jun; 77(7):2017-2023. PubMed ID: 35466357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections.
    Agnello S; Wardlow LC; Reed E; Smith JM; Coe K; Day SR
    Int J Antimicrob Agents; 2021 Aug; 58(2):106363. PubMed ID: 34033912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center.
    Pollett S; Baxi SM; Rutherford GW; Doernberg SB; Bacchetti P; Chambers HF
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4684-9. PubMed ID: 27216053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Concomitant Empiric Cefepime on Patient Outcomes of Methicillin-Resistant
    Zasowski EJ; Trinh TD; Atwan SM; Merzlyakova M; Langf AM; Bhatia S; Rybak MJ
    Open Forum Infect Dis; 2019 Jul; 6(7):ofz077. PubMed ID: 31338381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Concomitant Empiric Cefepime on Patient Outcomes of Methicillin-Resistant
    Zasowski EJ; Trinh TD; Atwan SM; Merzlyakova M; Langf AM; Bhatia S; Rybak MJ
    Open Forum Infect Dis; 2019 Apr; 6(4):ofz079. PubMed ID: 30968053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study.
    Jorgensen SCJ; Zasowski EJ; Trinh TD; Lagnf AM; Bhatia S; Sabagha N; Abdul-Mutakabbir JC; Alosaimy S; Mynatt RP; Davis SL; Rybak MJ
    Clin Infect Dis; 2020 Jun; 71(1):1-10. PubMed ID: 31404468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?
    Paul M; Zemer-Wassercug N; Talker O; Lishtzinsky Y; Lev B; Samra Z; Leibovici L; Bishara J
    Clin Microbiol Infect; 2011 Oct; 17(10):1581-6. PubMed ID: 21073629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.